Abstract:Synergistic therapeutic effect through the intracellular co-delivery of chemotherapy and biomacromolecule drugs is a novel strategy for improving tumor treatment effectiveness. A triblock copolymer, poly(acrylic acid)-poly(N, N-diisopropylaminoethyl methacrylate)-poly(N-vinylcaprolactam) (PAA-PDPA-PNVCL), was designed and synthesized for the construction of smart responsive drug carriers. The structure of the polymers was verified by nuclear magnetic resonance spectroscopy (1H-NMR) and fluorescence spectrophotometer (FL). The transmittances of the polymer solutions under different pH values or temperatures were measured by ultraviolet-visible spectroscopy (UV-Vis). Results showed that the polymer had excellent pH responsiveness and a low critical solution temperature (LCST), which could self-assemble into vesicles with PAA as hydrophilic shell, PDPA as hydrophobic intermediate layer and PNVCL as hydrophilic cavity. Then, the PAA shell layer was crosslinked with disulfide bonds through amide reaction, to improve the structural stability of vesicles and meanwhile introduce the reduction sensitivity. The changes of the particle size, Zeta potential, and morphology of the vesicle under different conditions were studied by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Results showed that the shell-crosslinked vesicles were uniformly sized spherical structure with good pH value and reduction responsiveness. Their drug encapsulation effect and in-vitro release behavior under different pH values and glutathione (GSH) concentrations were studied by UV-Vis and FT-IR. Results showed that the carriers could achieve zoned and co-loading of hydrophobic small molecule drug (doxorubicin (DOX)) and hydrophilic macromolecular protein drug model (bovine serum protein (BSA)). The hydrophobic layer of PDPA and the crosslinked layer of PAA provided dual-blockade for drug leakage. The leakage of drugs under normal physiological conditions was low, and the release of DOX and BSA could only be triggered under simulated tumor microenvironment, that is, weak acid and high concentration of GSH conditions. The smart responsive drug carriers constructed in this paper are expected to achieve co-delivery of chemotherapy and biomacromolecule drugs, which have potential application value to the clinical treatment of tumors.

Acidity/carbon Dioxide-Sensitive Triblock Polymer-Grafted Photoactivated Vesicles for Programmed Release of Chemotherapeutic Drugs Against Glioblastoma.

Well-Defined Polyethylene Glycol Microscale Hydrogel Blocks Containing Gold Nanorods for Dual Photothermal and Chemotherapeutic Therapy

Poly(ethylene Glycol) Based Nanotubes for Tuneable Drug Delivery to Glioblastoma Multiforme

On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma-Targeting Therapy

Dual-Responsive Polymer Vesicles Capable of Co-loading Two Antitumor Drugs

Photothermal gold nanocages filled with temperature sensitive tetradecanol and encapsulated with glutathione responsive polycurcumin for controlled DOX delivery to maximize anti-MDR tumor effects

Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for Ph-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism

PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.

In Vitro and in Vivo Evaluation of Stimuli-Responsive Vesicle from PEGylated Hyperbranched PAMAM-doxorubicin Conjugate for Gastric Cancer Therapy.

Controlled release of DOX mediated by glutathione and pH dual-responsive hollow mesoporous silicon coated with polydopamine graft poly(poly(ethylene glycol) methacrylate) nanoparticles for cancer therapy

Mild Hyperthermia-Enhanced Chemo-Photothermal Synergistic Therapy Using Doxorubicin-Loaded Gold Nanovesicles

Programmable Therapeutic Nanodevices with Circular Amplification of H2 O2 in the Tumor Microenvironment for Synergistic Cancer Therapy

Ph-Responsive Polymeric Micelles Based on Poly(2-Ethyl-2-oxazoline)-poly(d,l-lactide) for Tumor-Targeting and Controlled Delivery of Doxorubicin and P-glycoprotein Inhibitor

Dual-phase injectable thermosensitive hydrogel incorporating Fe3O4@PDA with pH and NIR triggered drug release for synergistic tumor therapy

Lactobionic Acid-Navigated Gold Nanorods With Light-Triggered “on-Demand” Drug Release for Synergistic Photothermal-Chemotherapy

Highly cell-penetrating and ultra-pH-responsive nanoplatform for controlled drug release and enhanced tumor therapy

pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma

Therapeutic Polymeric Nanomedicine: GSH-responsive Release Promotes Drug Release for Cancer Synergistic Chemotherapy.

Self-accelerating H2O2-responsive Plasmonic Nanovesicles for Synergistic Chemo/starving therapy of Tumors.

Dual‐responsive polycarbonate micelles for activating intracellular drug release

Augmented Glioma-Targeted Theranostics Using Multifunctional Polymer-Coated Carbon Nanodots.